Physician

Caitlin D Tourje, M.D.

According to 2025 Medicare claims, Caitlin Tourje, M.D. (NPI: 1033571872) practices anesthesiology in the Oxnard-Thousand Oaks-Ventura, CA market, with the plurality of this provider's patient population coming from Ventura, CA. This provider's primary affiliated billing organization is SPANISH HILLS INTERVENTIONAL PAIN SPECIALISTS INC A MEDICAL CORP (NPI: 1205195732; TIN: 371636304) and primary practice location at 93010-6073. Tourje is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Tourje's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 530 traditional Medicare patients, billed 4,296 HCPCS/CPT codes, and received $780,031 in Medicare payments. The top billing code was J7999 (Compounded drug, not otherwise classified). Part D data shows 1,135 prescription claims across 176 beneficiaries totaling $164,111 in drug costs, led by Belbuca (Buprenorphine Hcl). Open Payments data shows 189 records totaling $28,158. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $7,472 to $164,111. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$390K$780K2021 Medicare payment: $25,254 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $100,882 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $127,636 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $780,031 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202188275$25,254
20221701,323$100,882
20231911,801$127,636
20245304,296$780,031

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$82K$164K2016 Drug cost: $7,472 (USD; Tot_Drug_Cst)2017 Drug cost: $4,041 (USD; Tot_Drug_Cst)2018 Drug cost: $1,263 (USD; Tot_Drug_Cst)2019 Drug cost: $426 (USD; Tot_Drug_Cst)2020 Drug cost: $5,621 (USD; Tot_Drug_Cst)2021 Drug cost: $51,973 (USD; Tot_Drug_Cst)2022 Drug cost: $106,957 (USD; Tot_Drug_Cst)2023 Drug cost: $131,769 (USD; Tot_Drug_Cst)2024 Drug cost: $164,111 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
201634117$7,472
20171150$4,041
2018N/R20$1,263
2019N/R16$426
202073129$5,621
2021238570$51,973
202284626$106,957
2023118982$131,769
20241761,135$164,111

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J7999Compounded drug, not otherwise classified53171$2,887
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more115115$135
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4601,661$106
62370Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician56170$80
62323Injection of substance into lower spine canal using imaging guidance7191$76

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
BelbucaBuprenorphine Hcl361,012$27,925
UbrelvyUbrogepant16440$23,569
QuliptaAtogepant21630$22,537
LicartDiclofenac Epolamine26780$18,025
ZtlidoLidocaine401,320$15,131

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.189$28,158BIOTRONIK NRO, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Caitlin D. Tourje, M.D.?

Tedicare shows public-source Medicare data for Caitlin D. Tourje, M.D. (NPI 1033571872), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Caitlin D. Tourje, M.D. have ACO affiliation data?

Caitlin D. Tourje, M.D. is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Caitlin D. Tourje, M.D.?

Caitlin D. Tourje, M.D. is linked to SPANISH HILLS INTERVENTIONAL PAIN SPECIALISTS INC A MEDICAL CORP (billing NPI 1205195732) in the available physician profile data.

Does Caitlin D. Tourje, M.D. have Open Payments data?

Caitlin D. Tourje, M.D. has 189 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.